
Dr Leslie Eiland on the Continued Use of Technology for T1D, Post Pandemic
Leslie Eiland, MD, offers insights on whether use of certain technologies among patients with type 1 diabetes (T1D) will continue after the pandemic ends.
Overall, telehealth visits are not equitable for all patients with type 1 diabetes (T1D), said Leslie Eiland, MD, an endocrinologist at the University of Nebraska Medical Center in Omaha, Nebraska.
Transcript
Do you think care technology use among patients with T1D will continue once the pandemic ends?
I hope
But that's not all of my patients. It's a percentage of my patients. But overall, these visits are not equitable, right? Not everyone has access to a smartphone or lives in a place with stable internet or can afford stable internet or has the literacy needed to troubleshoot and initiate these videos. I think that the clinics that we do at these rural community hospitals do address these exact disparities and give people the stable internet connection they need to have a visit. There's somebody available to help troubleshoot. If there any technical issues, they're not responsible for that. So I think home visits are great for a lot of people, but I don't think they should take the place of these more traditional telehealth sites at
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.